Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1997 Jul;73(861):386–390. doi: 10.1136/pgmj.73.861.386

Maintenance pharmacological immunosuppressive strategies in renal transplantation.

J P Vella 1, M H Sayegh 1
PMCID: PMC2431407  PMID: 9338020

Abstract

Current maintenance immunosuppressive regimens for transplantation are based on three classes of drugs: corticosteroids, immunophilin-binding agents (eg, cyclosporin and tacrolimus), and antimetabolites (eg, azathioprine and mycophenolate). Drugs from the various classes inhibit the immune system at different points and are thus synergistic when used in combination.

Full text

PDF
386

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azuma H., Binder J., Heemann U., Tullius S. G., Tilney N. L. Effect of RS61443 on chronic rejection of rat kidney allografts. Transplant Proc. 1995 Feb;27(1):436–437. [PubMed] [Google Scholar]
  2. Braun W. E. Long-term complications of renal transplantation. Kidney Int. 1990 May;37(5):1363–1378. doi: 10.1038/ki.1990.123. [DOI] [PubMed] [Google Scholar]
  3. Carpenter C. B. Long-term failure of renal transplants: adding insult to injury. Kidney Int Suppl. 1995 Aug;50:S40–S44. [PubMed] [Google Scholar]
  4. Chung J., Kuo C. J., Crabtree G. R., Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell. 1992 Jun 26;69(7):1227–1236. doi: 10.1016/0092-8674(92)90643-q. [DOI] [PubMed] [Google Scholar]
  5. Dunn J., Golden D., Van Buren C. T., Lewis R. M., Lawen J., Kahan B. D. Causes of graft loss beyond two years in the cyclosporine era. Transplantation. 1990 Feb;49(2):349–353. doi: 10.1097/00007890-199002000-00024. [DOI] [PubMed] [Google Scholar]
  6. Gray D., Shepherd H., Daar A., Oliver D. O., Morris P. J. Oral versus intravenous high-dose steroid treatment of renal allograft rejection. The big shot or not? Lancet. 1978 Jan 21;1(8056):117–118. doi: 10.1016/s0140-6736(78)90417-8. [DOI] [PubMed] [Google Scholar]
  7. Gupta A. K., Cardella C. J., Haberman H. F. Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol. 1986 Nov;122(11):1288–1293. [PubMed] [Google Scholar]
  8. Halloran P. F. New trends in immunosuppression for renal transplantation. Curr Opin Nephrol Hypertens. 1994 Nov;3(6):575–577. doi: 10.1097/00041552-199411000-00002. [DOI] [PubMed] [Google Scholar]
  9. Heaf J. Bone marrow function during quadruple immunosuppressive therapy after renal transplantation. Clin Nephrol. 1993 Dec;40(6):332–338. [PubMed] [Google Scholar]
  10. Heim-Duthoy K. L., Chitwood K. K., Tortorice K. L., Massy Z. A., Kasiske B. L. Elective cyclosporine withdrawal 1 year after renal transplantation. Am J Kidney Dis. 1994 Nov;24(5):846–853. doi: 10.1016/s0272-6386(12)80680-9. [DOI] [PubMed] [Google Scholar]
  11. Hricik D. E., Almawi W. Y., Strom T. B. Trends in the use of glucocorticoids in renal transplantation. Transplantation. 1994 Apr 15;57(7):979–989. [PubMed] [Google Scholar]
  12. Jordan M. L., Shapiro R., Vivas C. A., Scantlebury V. P., Rhandhawa P., Carrieri G., McCauley J., Demetris A. J., Tzakis A., Fung J. J. FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation. 1994 Mar 27;57(6):860–865. doi: 10.1097/00007890-199403270-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kahan B. D. Cyclosporine. N Engl J Med. 1989 Dec 21;321(25):1725–1738. doi: 10.1056/NEJM198912213212507. [DOI] [PubMed] [Google Scholar]
  14. Kahan B. D. Cyclosporine: a powerful addition to the immunosuppressive armamentarium. Am J Kidney Dis. 1984 May;3(6):444–455. doi: 10.1016/s0272-6386(84)80009-8. [DOI] [PubMed] [Google Scholar]
  15. Kovarik J. M., Mueller E. A., van Bree J. B., Flückiger S. S., Lange H., Schmidt B., Boesken W. H., Lison A. E., Kutz K. Cyclosporine pharmacokinetics and variability from a microemulsion formulation--a multicenter investigation in kidney transplant patients. Transplantation. 1994 Sep 27;58(6):658–663. [PubMed] [Google Scholar]
  16. Nickerson P. W., Steurer W., Steiger J., Strom T. B. In pursuit of the "holy grail": allograft tolerance. Kidney Int Suppl. 1994 Jan;44:S40–S49. [PubMed] [Google Scholar]
  17. Penn I. Cancers complicating organ transplantation. N Engl J Med. 1990 Dec 20;323(25):1767–1769. doi: 10.1056/NEJM199012203232510. [DOI] [PubMed] [Google Scholar]
  18. Porayko M. K., Textor S. C., Krom R. A., Hay J. E., Gores G. J., Richards T. M., Crotty P. H., Beaver S. J., Steers J. L., Wiesner R. H. Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation. Mayo Clin Proc. 1994 Feb;69(2):105–111. doi: 10.1016/s0025-6196(12)61034-9. [DOI] [PubMed] [Google Scholar]
  19. Rubin R. H. Infectious disease complications of renal transplantation. Kidney Int. 1993 Jul;44(1):221–236. doi: 10.1038/ki.1993.234. [DOI] [PubMed] [Google Scholar]
  20. Sanders C. E., Curtis J. J., Julian B. A., Gaston R. S., Jones P. A., Laskow D. A., Deierhoi M. H., Barber W. H., Diethelm A. G. Tapering or discontinuing cyclosporine for financial reasons--a single-center experience. Am J Kidney Dis. 1993 Jan;21(1):9–15. doi: 10.1016/s0272-6386(12)80713-x. [DOI] [PubMed] [Google Scholar]
  21. Sayegh M. H., Krensky A. M. Novel immunotherapeutic strategies using MHC derived peptides. Kidney Int Suppl. 1996 Jan;53:S13–S20. [PubMed] [Google Scholar]
  22. Sayegh M. H., Turka L. A. T cell costimulatory pathways: promising novel targets for immunosuppression and tolerance induction. J Am Soc Nephrol. 1995 Oct;6(4):1143–1150. doi: 10.1681/ASN.V641143. [DOI] [PubMed] [Google Scholar]
  23. Sollinger H. W., Belzer F. O., Deierhoi M. H., Diethelm A. G., Gonwa T. A., Kauffman R. S., Klintmalm G. B., McDiarmid S. V., Roberts J., Rosenthal J. T. RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection. Ann Surg. 1992 Oct;216(4):513–519. doi: 10.1097/00000658-199210000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Watschinger B., Sayegh M. H. Endothelin in organ transplantation. Am J Kidney Dis. 1996 Jan;27(1):151–161. doi: 10.1016/s0272-6386(96)90045-1. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES